National HealthCare Corp. Hits New 52-Week High at $215.19

National HealthCare Corp. has reached a significant milestone by hitting a new 52-week high of USD 215.19 on July 1, 2026. This achievement highlights the company's strong performance in the hospital industry, particularly impressive given its market capitalization of USD 2,503 million, categorizing it as a small-cap stock. Over the past year, National HealthCare Corp. has demonstrated remarkable growth, with a performance increase of 159.43%, significantly outpacing the S&P 500's 20.74% gain during the same period. The company's price-to-earnings (P/E) ratio stands at 21.00, indicating a solid valuation relative to its earnings. Additionally, National HealthCare Corp. offers a dividend yield of 1.56%, which may appeal to income-focused investors. With a return on equity of 10.96% and a price-to-book ratio of 2.34, the company showcases effective management of its equity and assets. The stock's previous 52-week low was recorded at USD 93.54, marking a substantial recovery and growth trajectory for National HealthCare Corp. as it continues to navigate the competitive landscape of the healthcare sector.